Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
Each subsidiary may utilize the CPB platform capabilities to commercialize products independently or through strategic collaborations. The subsidiaries’ diverse product pipeline mitigates the risk associated with individual development and drive opportunities forward.
Human Health
Human Microbiome
Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
2022
IBD – initiate scale-up for GMP production of drug candidate for IBD
Immuno-oncology – readout from proof-of-concept, first in human study
2023
IBD – clinical batch production of drug candidate for IBD as preparation for Phase 1 clinical trials in USA
Immuno-oncology – pre-IND meeting with FDA
Agriculture
Ag Biologicals
Lavie Bio Mission: Improve food quality, sustainability and agriculture productivity through
microbiome based ag-biologicals technology and products
2022
Bio-stimulants – build infrastructure for scale-up in ‘Thrivus™’ sales for spring wheat in 2023
Bio-fungicides – file for regulatory approval for leading product candidate LAV311 for fruit rot
2023
Bio-stimulants – ‘Thrivus™’ product sales expansion in US and Canada for spring wheat
Bio-fungicides - file for regulatory approval for leading product candidate LAV321 or LAV322 for downy mildew
Agriculture
Ag-Chemicals
AgPlenus Mission: Design of next-generation effective and sustainable crop protection products by leveraging predictive biology and chemistry
2022
New MoA herbicides – enter an additional collaboration agreement
New MoA herbicide – expand data package for APTH1, AgPlenus’ leading new MoA protein for the development of novel herbicides
2023
New MoA herbicides – reach milestone in one of the ongoing collaborations
New MoA fungicide – initial greenhouse readouts
Human Health
Medical Cannabis
Canonic Mission: Commercialize effective, precise and stable medical cannabis products, based on decoding plant genetics, for optimized therapeutic effect
2022
MetaYield – commercial launch of second- generation products in Israel
Precise – collect user data for clinical indications to support commercial launch in 2023
2023
MetaYield – commercial launch of first product in Europe
Precise – commercial launch of first product in Israel
Industrial Applications
Castor Oil Production
Castera Mission: Provide farmers with the most advanced Castor seeds & Ag-service solutions